---
created: '2026-02-09T05:54:32.183169Z'
description: Potent first-generation typical antipsychotic (butyrophenone). Widely
  used for acute agitation, Tourette syndrome, and psychosis.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/drug/haloperidol/
slug: haloperidol
tags:
- drug
- antipsychotic
- agitation
- tourette_syndrome
- imported
- primekg
templateEngineOverride: njk
title: Haloperidol
type: drug
updated: '2026-02-09T05:54:32.183169Z'
---

{% raw %}
<h1>Haloperidol</h1>
<h2>Overview</h2>
<p>Haloperidol is a high-potency <strong>typical antipsychotic</strong> of the butyrophenone class. It is one of the most frequently used antipsychotics in emergency settings for <strong>acute agitation</strong> or psychosis due to its rapid onset (especially IM) and relatively clean cardiovascular profile (less hypotension than chlorpromazine).</p>
<p>However, its high affinity for D2 receptors in the striatum leads to a high incidence of <strong>Extrapyramidal Symptoms (EPS)</strong>, such as dystonia, akathisia, and parkinsonism.</p>
<h2>Indications</h2>
<ul>
<li><strong>Schizophrenia</strong>: Acute and maintenance treatment.</li>
<li><strong>Acute Psychosis/Agitation</strong>: Emergency management.</li>
<li><strong>Tourette Syndrome</strong>: Control of tics.</li>
<li><strong>Delirium</strong>: Often used in ICU settings (though evidence is debated).</li>
<li><strong>Huntington's Disease</strong>: Chorea management.</li>
</ul>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>← [[Imipramine]] (drug)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:59.154865'
source: obsidian
</code></pre>
<ul>
<li>← [[Dopamine]] (neurotransmitter)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:34.905107'
source: obsidian
</code></pre>
<ul>
<li>→ [[Imipramine]] (drug)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[QT_Prolongation]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Dopamine_D2_Receptor]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Technetium_Tc-99m_pyrophosphate]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Methadyl_acetate]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Botulinum_Toxin_Type_B]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Extrapyramidal_Symptoms]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Methylprednisolone_hemisuccinate]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Tardive_Dyskinesia]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Chenodeoxycholic_acid]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[1-2-Phenylethyl-4-phenyl-4-acetoxypiperidine]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Sigma-1_Receptor]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-1_Adrenergic_Receptor]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Nalidixic_acid]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Tourette_Syndrome]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Estrone_sulfate]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Iofetamine_I-123]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[Gadobenic_acid]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:58.723650'
source: obsidian
</code></pre>
<ul>
<li>→ [[QT_Prolongation]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:41.747424'
source: obsidian
</code></pre>
<ul>
<li>→ [[Tourette_Syndrome]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:41.747424'
source: obsidian
</code></pre>
<ul>
<li>→ [[Dopamine_D2_Receptor]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:41.747424'
source: obsidian
</code></pre>
<ul>
<li>→ [[Tardive_Dyskinesia]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:41.747424'
source: obsidian
</code></pre>
<ul>
<li>→ [[Delirium]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:41.747424'
source: obsidian
</code></pre>
<ul>
<li>→ [[Extrapyramidal_Symptoms]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:41.747424'
source: obsidian
</code></pre>
<ul>
<li>→ [[Agitation]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:41.747424'
source: obsidian
</code></pre>
<ul>
<li>→ [[Sigma-1_Receptor]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:41.747424'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-1_Adrenergic_Receptor]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:41.747424'
source: obsidian
</code></pre>
<ul>
<li>→ [[Schizophrenia]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:41.747424'
source: obsidian
</code></pre>
<ul>
<li>→ [[Dopamine]] (neurotransmitter)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:41.747424'
source: obsidian
</code></pre>
<h3>Interactswith</h3>
<ul>
<li>← [[Methylprednisolone_hemisuccinate]] (entity)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:38.309000+00:00'
source: PrimeKG
</code></pre>
<ul>
<li>← [[Botulinum_Toxin_Type_B]] (entity)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:38.319000+00:00'
source: PrimeKG
</code></pre>
<ul>
<li>← [[Technetium_Tc-99m_pyrophosphate]] (entity)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:38.331000+00:00'
source: PrimeKG
</code></pre>
<ul>
<li>← [[Chenodeoxycholic_acid]] (entity)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:38.360000+00:00'
source: PrimeKG
</code></pre>
<ul>
<li>← [[Gadobenic_acid]] (entity)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:38.379000+00:00'
source: PrimeKG
</code></pre>
<ul>
<li>← [[Estrone_sulfate]] (entity)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:38.403000+00:00'
source: PrimeKG
</code></pre>
<ul>
<li>← [[Nalidixic_acid]] (entity)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:38.487000+00:00'
source: PrimeKG
</code></pre>
<ul>
<li>← [[Iofetamine_I-123]] (entity)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:38.493000+00:00'
source: PrimeKG
</code></pre>
<ul>
<li>← [[Methadyl_acetate]] (entity)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:38.517000+00:00'
source: PrimeKG
</code></pre>
<ul>
<li>← [[1-2-Phenylethyl-4-phenyl-4-acetoxypiperidine]] (entity)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:38.528000+00:00'
source: PrimeKG
</code></pre>
<ul>
<li>→ [[Imipramine]] (drug)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:36.989000+00:00'
source: PrimeKG
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<h3>Modulates Neurotransmitter</h3>
<ul>
<li>⊣ [[Dopamine]] (neurotransmitter) - <em>Potent D2 antagonism</em></li>
</ul>
<h3>Modulates Protein</h3>
<ul>
<li>⊣ [[Dopamine D2 Receptor]] (protein) - <em>High Affinity Antagonist</em></li>
<li>⊣ [[Alpha-1 Adrenergic Receptor]] (protein) - <em>Antagonist</em></li>
<li>⊣ [[Sigma-1 Receptor]] (protein) - <em>Antagonist</em></li>
</ul>
<h3>Treats Condition</h3>
<ul>
<li>→ [[Schizophrenia]] (condition)</li>
<li>→ [[Agitation]] (condition)</li>
<li>→ [[Tourette Syndrome]] (condition)</li>
<li>→ [[Delirium]] (condition)</li>
</ul>
<h3>Adverse Effects</h3>
<ul>
<li>→ [[Extrapyramidal Symptoms]] (condition) - <em>High risk</em></li>
<li>→ [[Tardive Dyskinesia]] (condition)</li>
<li>→ [[QT Prolongation]] (condition)</li>
</ul>
<h2>References</h2>
<ol>
<li><strong>Clinical Use</strong>: Joy, C. B., et al. (2006). &quot;Haloperidol versus placebo for schizophrenia.&quot; <em>Cochrane Database of Systematic Reviews</em>.</li>
<li><strong>Agitation</strong>: Wilson, M. P., et al. (2012). &quot;The psychopharmacology of agitation: consensus statement...&quot; <em>Western Journal of Emergency Medicine</em>.</li>
</ol>

{% endraw %}